PolyPeptide Group AG (0AAJ) Stock Statistics & Valuation Metrics
Total Valuation
PolyPeptide Group AG has a market cap or net worth of CHF 1.39B. The enterprise value is CHF 1.63B.
- Market Cap
- CHF 1.39B
- Enterprise Value
- CHF 1.63B
Share Statistics
PolyPeptide Group AG has 33,125,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 33,125,000
- Owned by Insiders
- ―
- Owned by Institutions
- 3.43%
Financial Efficiency
PolyPeptide Group AG’s return on equity (ROE) is -0.06 and return on invested capital (ROIC) is 1.14%.
- Return on Equity (ROE)
- -0.06
- Return on Assets (ROA)
- -0.03
- Return on Invested Capital (ROIC)
- 1.14%
- Return on Capital Employed (ROCE)
- 0.01
- Revenue Per Employee
- 268.40K
- Profits Per Employee
- -14.59K
- Employee Count
- 1,460
- Asset Turnover
- 0.47
- Inventory Turnover
- 2.13
Valuation Ratios
The current PE Ratio of PolyPeptide Group AG is 106.10. PolyPeptide Group AG’s PEG ratio is 0.39.
- PE Ratio
- 106.10
- PS Ratio
- 3.28
- PB Ratio
- 4.28
- Price to FCF
- -30.28
- Price to Operating Cash Flow
- 28.64
- PEG Ratio
- 0.39
Income Statement
In the last 12 months, PolyPeptide Group AG had revenue of 391.87M and earned -21.31M in profits. Earnings per share was -0.64.
- Revenue
- 391.87M
- Gross Profit
- 64.32M
- Operating Income
- 7.41M
- Pretax Income
- -21.41M
- Net Income
- -21.31M
- EBITDA
- 45.48M
- Earnings Per Share (EPS)
- -0.64
Cash Flow
In the last 12 months, operating cash flow was 52.60M and capital expenditures -102.35M, giving a free cash flow of -49.75M billion.
- Operating Cash Flow
- 52.60M
- Free Cash Flow
- -49.75M
- Free Cash Flow per Share
- -1.51
Dividends & Yields
PolyPeptide Group AG pays an annual dividend of CHF 0.30, resulting in a dividend yield of ―
- Dividend Per Share
- CHF 0.30
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -3.30%
- Earnings Yield
- 0.96%
Stock Price Statistics
- Beta
- 0.94
- 52-Week Price Change
- 64.84%
- 50-Day Moving Average
- 43.98
- 200-Day Moving Average
- 37.63
- Relative Strength Index (RSI)
- 17.58
- Average Volume (3m)
- 38.13K
Important Dates
PolyPeptide Group AG upcoming earnings date is Mar 09, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Mar 09, 2027
- Ex-Dividend Date
- Apr 28, 2022
Financial Position
PolyPeptide Group AG as a current ratio of 1.74, with Debt / Equity ratio of 38.33%
- Current Ratio
- 1.74
- Quick Ratio
- 0.91
- Debt to Market Cap
- 0.12
- Net Debt to EBITDA
- 1.23
- Interest Coverage Ratio
- 0.40
Taxes
In the past 12 months, PolyPeptide Group AG has paid -106.69K in taxes.
- Income Tax
- -106.69K
- Effective Tax Rate
- 0.00
Enterprise Valuation
PolyPeptide Group AG EV to EBITDA ratio is 20.08, with an EV/FCF ratio of -31.89.
- EV to Sales
- 3.46
- EV to EBITDA
- 20.08
- EV to Free Cash Flow
- -31.89
- EV to Operating Cash Flow
- 30.16
Balance Sheet
PolyPeptide Group AG has CHF 59.21M in cash and marketable securities with CHF 139.52M in debt, giving a net cash position of -CHF 80.30M billion.
- Cash & Marketable Securities
- CHF 59.21M
- Total Debt
- CHF 139.52M
- Net Cash
- -CHF 80.30M
- Net Cash Per Share
- -CHF 2.42
- Tangible Book Value Per Share
- CHF 10.47
Margins
Gross margin is 22.58%, with operating margin of 6.98%, and net profit margin of 3.15%.
- Gross Margin
- 22.58%
- Operating Margin
- 6.98%
- Pretax Margin
- 5.48%
- Net Profit Margin
- 3.15%
- EBITDA Margin
- 17.22%
- EBIT Margin
- 6.98%
Analyst Forecast
The average price target for PolyPeptide Group AG is CHF 44.10, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- CHF 44.10
- Price Target Upside
- 4.51% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 3
- Revenue Growth Forecast
- 22.06%
- EPS Growth Forecast
- ―
